Organogenesis Holdings (ORGO) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Organogenesis Holdings (ORGO) is Neutral.

The composite score behind that read is -0.01, weighing +0.34 of bullish evidence against -0.24 bearish.

Organogenesis Holdings last closed at $1.29, +0.78% on the session.

Against the IVW growth benchmark the position is -0.02% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

3 graded predictions for ORGO so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Organogenesis Holdings in the 20th percentile on return on equity, where 100 is best.

Organogenesis Holdings is classified under Health Care / Biotechnology, with a market capitalisation of $164.70M.

StockMap tracks Organogenesis Holdings as the 255th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Organogenesis Holdings ranks 116th of 381 in the group, against a group median of -0.08.